| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 268 |
| 1 | DOCETAXEL ANHYDROUS | 268 |
| 2 | TRASTUZUMAB | 81 |
| 3 | CARBOPLATIN | 70 |
| 4 | PERTUZUMAB | 60 |
| 5 | CYCLOPHOSPHAMIDE | 18 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 18 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 18 |
| 8 | DEXAMETHASONE | 10 |
| 9 | DEXAMETHASONE 1.5 MG | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOCETAXEL ANHYDROUS | 268 | 0.0039 |
| 1 | DOCETAXEL | 268 | 0.0039 |
| 2 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 3 | PERTUZUMAB | 60 | 0.0022 |
| 4 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 5 | TRASTUZUMAB | 81 | 0.0012 |
| 6 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| 7 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| 8 | SODIUM FLUORIDE F18 | 1 | 0.0009 |
| 9 | SODIUM FLUORIDE F-18 | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 268 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 82 |
| 2 | Platinum-based Drug [EPC] | 72 |
| 3 | Alkylating Drug [EPC] | 20 |
| 4 | Corticosteroid [EPC] | 14 |
| 5 | Leukocyte Growth Factor [EPC] | 8 |
| 6 | Aromatase Inhibitor [EPC] | 7 |
| 7 | Kinase Inhibitor [EPC] | 5 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 268 | 0.0016 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 82 | 0.0011 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 3 | Platinum-based Drug [EPC] | 72 | 0.0003 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 5 | Anticholinergic [EPC] | 2 | 0.0001 |
| 6 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 20 | 0.0001 |
| 9 | Aromatase Inhibitor [EPC] | 7 | 0.0001 |